Thermo Fisher Scientific Inc TMO is trading higher Friday after the company issued full-year 2022 financial guidance above analyst estimates.
Thermo Fisher expects full-year 2022 earnings of $21.16 per share versus the estimate of $19.68 per share. The company expects full-year 2022 revenue to be $40.3 billion versus the estimate of $34.29 billion.
Thermo Fisher sells scientific instruments and laboratory equipment, diagnostics consumables and life science reagents.
TMO Price Action: Thermo Fisher has traded as low as $412.80 over a 52-week period. It's making a new 52-week high in trading today.
The stock was up 6.68% at $597.83 at time of publication.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
